title: Relapse to opioid use after treatment of chronic hepatitis C with pegylated interferon and ribavirin.
authors.affiliation: Portland VA Medical Center, 3710 S.W. U.S. Veteran Hospital Rd., P.O. Box 1035 (V3MHC), Portland, OR 97202, USA. annette.matthews@med.va.gov
authors.forename: Annette M
authors.initials: AM
authors.lastname: Matthews
authors.forename: Marian
authors.initials: M
authors.lastname: Fireman
authors.forename: Betsy
authors.initials: B
authors.lastname: Zucker
authors.forename: Michelle
authors.initials: M
authors.lastname: Sobel
authors.forename: Peter
authors.initials: P
authors.lastname: Hauser
mesh_terms: D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D016739:Behavior, Addictive / Q000175:diagnosis / Q000453:epidemiology / Q000523:psychology; D019970:Cocaine-Related Disorders / Q000453:epidemiology / Q000523:psychology / Q000534:rehabilitation; D015897:Comorbidity; D004334:Drug Administration Schedule; D005500:Follow-Up Studies; D019698:Hepatitis C, Chronic / Q000188:drug therapy* / Q000453:epidemiology; D006801:Humans; D007372:Interferons / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D008691:Methadone / Q000627:therapeutic use; D008875:Middle Aged; D009293:Opioid-Related Disorders / Q000453:epidemiology* / Q000523:psychology / Q000534:rehabilitation; D010347:Patient Care Planning; D012008:Recurrence; D012254:Ribavirin / Q000008:administration & dosage / Q000627:therapeutic use*; D018570:Risk Assessment; D015819:Substance Abuse, Intravenous / Q000453:epidemiology* / Q000523:psychology / Q000534:rehabilitation*; D016896:Treatment Outcome
chemical_list: D000998:Antiviral Agents; D012254:Ribavirin; D007372:Interferons; D008691:Methadone